Scott J. Charles has 25+ years of experience and a record of accomplishment across a spectrum of financial operations in public and private environments. Scott currently serves as CFO.

Prior to HealthComp, Scott served as CFO for Cytel, the largest provider of statistical and software advanced analytics for clinical trial design and execution. Scott played a lead role in the growth of Cytel globally and successful sale. Before joining Cytel, Scott served as CFO of Aralez Pharmaceuticals, a publicly-traded, specialty pharmaceutical company. Prior to Aralez, he served as the Vice President of Finance and Treasurer at Ikaria, Inc., a critical care pharmaceutical company. Scott played a lead role in the spin-off of Ikaria’s R&D operations and IPO and successful sale of its commercial business.

Earlier in his career, Scott served as Vice President of Finance and Treasurer at Reliant Pharmaceuticals, Inc. Previously, at Arthur Andersen, LLP, Scott was a Manager in the Assurance and Business Advisory Services practice.

He holds a Bachelor of Science degree in Business Administration from Bucknell University and is a Certified Public Accountant.